Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) Inhibitors

Quan Guo(Hunan University of Science and Engineering), Steve Jia(Pacific Biosciences (United States)), Guipeng Liu(China Medical University), Igor Nikoulin, Jun Li(China Medical University), Qing Yang(China Medical University)
Current Pharmaceutical Biotechnology
December 26, 2018
10.2174/1389201020666181226123054
Cited by 6

Related Papers

Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients
|Journal of Experimental & Clinical Cancer Research|2010|115
Autophagy is activated in the ovarian tissue of polycystic ovary syndrome
|Reproduction|2017|98
Pre-Eclampsia-Associated Reduction in Placental Growth Factor Impaired Beta Cell Proliferation Through PI3k Signalling
|Cellular Physiology and Biochemistry|2015|14
Tubal ectopic pregnancy occurrence is associated with high expressions of prokineticin receptors and aberrant secretion of inflammatory cytokines.
|PubMed|2020|14
Impaired proliferation of pancreatic beta cells, by reduced placental growth factor in pre‐eclampsia, as a cause for gestational diabetes mellitus
|Cell Proliferation|2015|12